PLUS1
1.85
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Low
0.025
High
5.67
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | ASP | Toronto | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.85 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.85 |
| Trades | Stocks Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.025 - 5.67 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.85 | CAD |
Period:
Draw Mode:
Acerus Pharmaceuticals Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 14.26M | - | - | $ -5.22M | $ 0.00 | -5.06 | -0.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 255.00 | $ - | - | 0.00 | - |
Acerus Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ASP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.00 | 2.00 | 1.80 | 1.86 | 153 | -0.15 | -7.5% |
| 1 Month | 2.90 | 2.90 | 1.80 | 2.27 | 371 | -1.05 | -36.21% |
| 3 Months | 2.87 | 3.36 | 1.69 | 2.72 | 498 | -1.02 | -35.54% |
| 6 Months | 0.045 | 5.67 | 0.025 | 0.1748748 | 23,881 | 1.81 | 4,011.11% |
| 1 Year | 0.035 | 5.67 | 0.025 | 0.0596234 | 69,439 | 1.82 | 5,185.71% |
| 3 Years | 0.095 | 5.67 | 0.025 | 0.0534694 | 176,498 | 1.76 | 1,847.37% |
| 5 Years | 0.135 | 5.67 | 0.025 | 0.1535034 | 196,028 | 1.72 | 1,270.37% |
Acerus Pharmaceuticals Description
| Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a... |
